Concepedia

Albane Courjaud

AC

Statistics

Publications

3

Citations

273

H-Index

3

Active since

2018

Affiliations

Sanofi (France)(Current)

Sanofi (United States)

Albane Courjaud is an author at Sanofi (France) specializing in medicine, hormonal cancer therapy, and hormonal therapy.

Publications per year

2018–2020

3

Publications

3

Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers

Malvika Koundinya, Judith Sudhalter, Albane Courjaud et al. · Cell chemical biology · 2018 · 125 citations

Medicine, Cancer Biology, Oncology +16

Discovery of 6-(2,4-Dichlorophenyl)-5-[4-[(3<i>S</i>)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7<i>H</i>-benzo[7]annulene-2-carboxylic acid (SAR439859), a Potent and Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen-Receptor-Positive Breast Cancer

Youssef El‐Ahmad, Michel Tabart, Frank Halley et al. · Journal of Medicinal Chemistry · 2019 · 81 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), Demonstrates Effective and Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Maysoun Shomali, Jane Cheng, Fangxian Sun et al. · Molecular Cancer Therapeutics · 2020 · 67 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3